Search

everythinglearnresearchcommunity

for

Search:↓

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

IGF-1 can boost hair growth by promoting cell growth and preventing cell death.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Bicalutamide may help treat female pattern hair loss.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Genetic analysis of rabbits identified key genes for traits like coat color, body size, and fertility.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Hair follicle growth and fiber production in animals are influenced by chemical signals, proteins, pigmentation, genetics, and nutrients.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Cerasus serrulata flower extracts have strong antibacterial and antioxidant effects and may help prevent hair loss.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Lower testosterone levels may increase heart failure risk in older men.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

PAR-1 may play a role in hair growth regulation in human hair follicles.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Most genetic mutations causing hypohidrotic ectodermal dysplasia in Russian patients are found in the EDA gene.